SYNAGISHCP.COM: Keyword Density Checker

Total words: 2813 | 2-word phrases: 740 | 3-word phrases: 820 | 4-word phrases: 853

PAGE INFO

Title	Try to keep the title under 60 characters (57 characters) Treatment for Highest-Risk RSV Patients \| SYNAGIS® \| HCP
Description	Try to keep the meta description between 50 - 160 characters (161 characters) Find out more about SYNAGIS® (palivizumab) for your patients, it provides proven protection against severe RSV disease in the highest-risk infants and children.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (58 characters) SYNAGIS®—PROVEN PROTECTION* AGAINST SEVERE RSV DISEASE1

#	Keyword	Frequency	Density
1	of age or	6	0.73%
2	months of age	6	0.73%
3	age or younger	6	0.73%
4	at the beginning	6	0.73%
5	the beginning of	6	0.73%
6	beginning of rsv	6	0.73%
7	of rsv season	6	0.73%
8	and who are	6	0.73%
9	respiratory syncytial virus	5	0.61%
10	are 24 months	4	0.49%
11	who are 24	4	0.49%
12	program is not	4	0.49%
13	24 months of	4	0.49%
14	this program is	3	0.37%
15	congenital heart disease	3	0.37%
16	is not valid	3	0.37%
17	terms of use	3	0.37%
18	synagis 50 mg	2	0.24%
19	mg and 100	2	0.24%
20	50 mg and	2	0.24%
21	chd and who	2	0.24%
22	and 100 mg	2	0.24%
23	100 mg for	2	0.24%
24	mg for injection	2	0.24%
25	disease chd and	2	0.24%
26	heart disease chd	2	0.24%
27	indicated for the	2	0.24%
28	for the prevention	2	0.24%
29	indication synagis 50	2	0.24%
30	patients with a	2	0.24%

#	Keyword	Frequency	Density
1	at the beginning of	6	0.70%
2	of age or younger	6	0.70%
3	months of age or	6	0.70%
4	the beginning of rsv	6	0.70%
5	beginning of rsv season	6	0.70%
6	24 months of age	4	0.47%
7	who are 24 months	4	0.47%
8	are 24 months of	4	0.47%
9	and who are 24	4	0.47%
10	this program is not	3	0.35%
11	disease chd and who	2	0.23%
12	that required medical treatment	2	0.23%
13	of premature birth ≤35	2	0.23%
14	the date synagis was	2	0.23%
15	from the date synagis	2	0.23%
16	days from the date	2	0.23%
17	of rsv season with	2	0.23%
18	with bronchopulmonary dysplasia bpd	2	0.23%
19	bronchopulmonary dysplasia bpd that	2	0.23%
20	dysplasia bpd that required	2	0.23%
21	bpd that required medical	2	0.23%
22	the previous 6 months	2	0.23%
23	within the previous 6	2	0.23%
24	heart disease chd and	2	0.23%
25	previous 6 months and	2	0.23%
26	6 months and who	2	0.23%
27	months and who are	2	0.23%
28	younger at the beginning	2	0.23%
29	you are about to	2	0.23%
30	chd and who are	2	0.23%
31	rsv season with hemodynamically	2	0.23%
32	season with hemodynamically significant	2	0.23%
33	congenital heart disease chd	2	0.23%
34	is not valid for	2	0.23%
35	age or younger at	2	0.23%
36	or younger at the	2	0.23%
37	serious lower respiratory tract	2	0.23%
38	a history of premature	2	0.23%
39	with a history of	2	0.23%
40	patients with a history	2	0.23%

#	URL	Whois	Check
1	https://www.synagis.com	Whois	synagis.com
2	https://www.sobi.com/usa/en/terms-of-use-us	Whois	sobi.com
3	https://www.sobi.com/usa/en/privacy-policy-us	Whois	sobi.com
4	https://www.sobi.com/usa/en/contact-us	Whois	sobi.com
5	https://www.sobi.com/usa/en	Whois	sobi.com
6	https://synagis.com	Whois	synagis.com
7	https://www.sobi.com/usa/en/cookie-policy-us	Whois	sobi.com